A STEMI is a severe type of heart attack caused by a complete blockage in one of the coronary arteries, the blood vessels that supply oxygen to the heart muscle. The name stands for ST-elevation myocardial infarction, referring to a specific pattern that shows up on an electrocardiogram (ECG). Unlike other forms of heart attack where blood flow is only partially reduced, a STEMI cuts off circulation entirely to a section of the heart, making it a medical emergency where every minute of delay increases the risk of permanent damage.
How a STEMI Differs From Other Heart Attacks
Heart attacks fall into two broad categories based on what the ECG shows. In a STEMI, a coronary artery is fully blocked, usually by a blood clot that forms over a ruptured cholesterol plaque. Because no blood at all reaches the affected heart muscle, the damage is typically more extensive and more dangerous than in the other type, called an NSTEMI (non-ST-elevation myocardial infarction), where the artery is only partially blocked.
The distinction matters because it changes how urgently doctors need to act. A STEMI triggers an immediate protocol to reopen the artery, while an NSTEMI may allow a slightly wider window for evaluation before intervention. Both are serious, but a STEMI is treated as the more time-critical emergency.
What a STEMI Feels Like
The most common symptom is persistent chest pain, often described as pressure, squeezing, or tightness in the center or left side of the chest. In a large registry of heart attack patients in China, about two-thirds reported this classic chest pain. Heavy sweating with no obvious cause was nearly as common, affecting around 60 to 65% of patients. Other frequent symptoms include a feeling of tightness or heaviness in the chest without sharp pain, pain radiating to the jaw, neck, shoulder, or left arm, and fatigue.
Not everyone gets the textbook symptoms. People with diabetes are significantly less likely to experience classic chest pain, sweating, or radiating pain. Nerve damage from long-term high blood sugar blunts the pain signals the heart sends during a blockage. In the same registry, diabetes was an independent predictor of atypical symptoms. Women, older adults, and people with diabetes are all more likely to experience vague symptoms like shortness of breath, nausea, lightheadedness, or unexplained fatigue instead of crushing chest pain.
Who Is Most at Risk
The risk factors for a STEMI overlap heavily with those for heart disease in general, but a few stand out for their strength. In a study of young STEMI patients (age 45 and under) in Ireland, 90% were male, 69% were current smokers, and 63% were overweight or obese. Two-thirds had a family history of cardiovascular disease. Nearly 80% were either diabetic or pre-diabetic.
The major modifiable risk factors are smoking, high blood pressure, high cholesterol, obesity, and diabetes. Smoking is particularly notable because even patients with no family history of heart disease had STEMIs when they were smokers, highlighting how powerful lifestyle factors are. Non-modifiable risk factors include being male, older age, and a family history of cardiovascular disease.
How Doctors Confirm a STEMI
The diagnosis comes from an ECG, a quick test that records the heart’s electrical activity through sensors placed on the skin. Doctors look for a specific pattern: the ST segment, a particular portion of the ECG tracing, rises above its normal baseline. This elevation signals that a section of heart muscle is being starved of blood. The pattern appears in different leads (sensor positions) depending on which artery is blocked, which tells clinicians exactly where the damage is occurring.
Blood tests for a protein called troponin confirm the diagnosis. When heart muscle cells are injured, they release troponin into the bloodstream. Levels typically begin rising within 3 to 12 hours of a heart attack, peak around 24 hours, and stay elevated for five to seven days or longer. However, treatment decisions for a STEMI are made on the ECG alone because waiting for blood test results would waste critical time.
Why Speed of Treatment Matters
The standard treatment for a STEMI is a procedure called percutaneous coronary intervention, or PCI. A catheter is threaded through a blood vessel, usually from the wrist or groin, to the blocked artery, where a small balloon is inflated to open the blockage and a stent (a tiny mesh tube) is placed to keep the artery open. The American College of Cardiology and American Heart Association set the target at 90 minutes or less from the moment a patient arrives at the hospital to when the artery is reopened. This is called “door-to-balloon time.”
When PCI isn’t available quickly, for example in rural areas far from a hospital with a catheterization lab, clot-dissolving medication can be given instead. This approach works best when administered within the first 3 hours of symptom onset. After 3 hours, the benefit drops sharply. Guidelines recommend using clot-dissolving drugs when the expected delay to PCI exceeds 120 minutes. If symptoms started more than 12 hours ago, these medications generally aren’t effective.
Complications After a STEMI
The biggest immediate threat is a dangerous heart rhythm. Abnormal electrical activity is common in the early hours after a STEMI, and sudden death from a chaotic heart rhythm accounts for roughly 50% of all deaths in high-risk heart attack patients. The likelihood of rhythm problems increases with the size of the heart attack. In patients who develop cardiogenic shock (where the heart is too damaged to pump effectively), dangerous rhythms occur in roughly 17 to 29% of cases.
Longer-term complications depend on how much muscle was damaged before blood flow was restored. If a large area of the heart was affected, the muscle may weaken permanently, leading to heart failure, a condition where the heart can’t pump blood efficiently enough to meet the body’s needs. Some patients develop problems with heart valves or, rarely, a tear in the damaged heart wall. These risks are one reason rapid treatment is so critical: the sooner the artery is reopened, the more muscle is saved.
Survival and Prognosis
Outcomes have improved dramatically over recent decades thanks to faster treatment protocols and better medications. In a prospective study of 378 STEMI patients, in-hospital mortality was 6.6%, 30-day mortality was 10.1%, and one-year mortality was 17.2%. That means about 83% of patients survived at least a year. The numbers vary significantly depending on how quickly treatment was received, the size of the heart attack, the patient’s age, and whether complications like cardiogenic shock developed.
What Recovery Looks Like
After the acute crisis is over, most STEMI patients stay in the hospital for several days. Recovery begins there with the first phase of cardiac rehabilitation, which focuses on light movement and education about what happened.
The second phase starts after discharge: a structured outpatient program typically lasting 12 weeks, with three one-hour sessions per week (36 sessions total, usually covered by insurance and Medicare). These sessions combine supervised exercise with guidance from nutritionists, exercise specialists, and other providers. The goal is to rebuild cardiovascular fitness safely while making the lifestyle changes that reduce the risk of another event.
The third phase is lifelong. It means continuing the exercise habits, dietary changes, and medication routines on your own. Most patients are prescribed blood thinners, cholesterol-lowering medication, and blood pressure drugs after a STEMI, often for the rest of their lives. Quitting smoking, maintaining a healthy weight, and managing blood sugar are equally important parts of long-term prevention.